Lunesta
Product Images NDC 21695-225

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lunesta (NDC 21695-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (7b069c49 007c 4f77 878c 0a6c564e2717 01)

Chemical structure of the active ingredient in Lunesta. The diagram depicts the molecular structure with heterocyclic rings and functional groups including chlorine and nitrogen atoms visible in the molecular configuration.*

FDA Label Image

Lunesta 3mg (7b069c49 007c 4f77 878c 0a6c564e2717 02)

Lunesta 3 mg tablets packaging label showing a bottle of 30 tablets. The label includes the product name Lunesta, strength 3 mg, and mentions each tablet contains Eszopiclone 3 mg. It is marked RX Only and packed by Physician Partner. The label also displays NDC 21695-226-30 and manufacturer information: Patheon Inc., Mississauga, Ontario, Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.